Medocity to Demonstrate New Innovative Cancer Patient Care Platform at ASCO 2015
MORRISTOWN, NJ — Medocity, Inc. will demonstrate iCancerHealth™, a unique mobile and web platform designed to bridge the care gap between the clinic and the patient’s home, at the Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago from May 29 – June 2, 2015.
iCancerHealth is a patient-centric application that puts innovative care tools at the fingertips of cancer patients and their caregivers, along with access to timely disease and drug specific resources — all in one place to support key aspects of their care at home.
“More than one-and-a-half million people in the United States are diagnosed with cancer each year1,” said Raj Agarwal, President and CEO of Medocity. “Patients and caregivers are looking for better ways to empower and more effectively manage their care while undergoing cancer treatment, while leading the best quality of life possible at the same time.”
“As an oncologist, I realize that I can’t possibly know everything that is happening with my patients day-to-day after they leave my clinic,”said Dr. Mohit Narang, MD, Maryland Oncology Hematology Group Practice. “Having the patient and caregiver share progress between visits via iCancerHealth is invaluable to optimize their ongoing cancer care.“
The iCancerHealth platform merges healthcare, technology and patient outcomes to assist patients during their cancer treatment. It models real life scenarios based on patients’ care challenges at home and input from oncologists, nurses, patients and caregivers. With iCancerHealth, patients can share records of their daily health, side effects and symptoms with their physicians and nurses in a more comprehensive manner and helping them make more informed clinical decisions.
iCancerHealth is a free app available to patients and caregiver on Apple’s iTunes App Store and Google Play. It is an intuitive, comprehensive platform that:
- Manages and tracks medications, symptoms and treatment plans,
- Guides patients and caregivers with timely disease and drug specific information, and
- Connects the patients with their care teams, family and friends for better information sharing and support.
For Healthcare Providers, Medocity further extends the iCancerHealth platform with real-time connectivity between patients, cancer centers and healthcare teams, providing remote patient monitoring between visits, personalized guidance recommendations, and proactive interventions based on symptoms and side effects reported by patients in the home setting.
“Living with cancer is challenging, and our approach while designing iCancerHealth was to put the patient at the core of care,” said Agarwal. “We believe that the iCancerHealth platform will positively impact the daily lives of patients and caregivers while reducing avoidable costs associated with sub-optimal care at home. We are extremely pleased with the overwhelming response we have received from major cancer centers, academic institutions and patient advocacy groups.”
Founded in 1964, the American Society of Clinical Oncology (ASCO) is the world’s leading professional organization representing physicians who care for people with cancer. With more than 35,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation, which funds ground-breaking research and programs that make a tangible difference in the lives of people with cancer.
Medocity, headquartered in Parsippany, New Jersey, is a recognized leader in comprehensive virtual care products and services including chronic condition management, televisits, and remote patient monitoring. Our unique, innovative technology combines multiple telehealth capabilities onto a single, integrated care coordination and management platform, along with robust clinical intelligence including rules-based algorithms, alerts and decision support tools to help drive earlier detection and proactive interventions.
The Medocity platform is specifically designed to enable and improve patient-centered care delivered outside the hospital setting, particularly for patients at home who have chronic conditions responsible for more than 80% of the nation’s annual healthcare spend. By promoting patient-clinician engagement through shared connectivity and virtual technology, we enable rich, real-time interactions between patients, clinicians, care professionals and support teams.
Our vision is to dramatically improve care at lower cost for patients when they need it the most – when they’re at home, on their own, or in between visits with their care providers. Virtually. (http://www.medocity.com)